Characterization of the Proliferating Cell Nuclear Antigen of Leishmania donovani Clinical Isolates and Its Association with Antimony Resistance

被引:15
作者
Tandon, Rati [1 ]
Chandra, Sharat [2 ]
Baharia, Rajendra Kumar [1 ]
Das, Sanchita [1 ]
Misra, Pragya [1 ]
Kumar, Awanish [1 ]
Siddiqi, Mohammad Imran [2 ]
Sundar, Shyam [3 ]
Dube, Anuradha [1 ]
机构
[1] Cent Drug Res Inst, Div Parasitol, Lucknow, Uttar Pradesh, India
[2] Cent Drug Res Inst, Div Struct & Mol Biol, Lucknow 226001, Uttar Pradesh, India
[3] Banaras Hindu Univ, Inst Med Sci, Dept Med, Varanasi 221005, Uttar Pradesh, India
关键词
IN-VITRO; DRUG-RESISTANCE; NITRIC-OXIDE; PROTEIN; PCNA; VIVO; PEPTIDES; IDENTIFICATION; PROMASTIGOTE; EXPRESSION;
D O I
10.1128/AAC.01847-13
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Previously, through a proteomic analysis, proliferating cell nuclear antigen (PCNA) was found to be overexpressed in the sodium antimony gluconate (SAG)-resistant clinical isolate compared to that in the SAG-sensitive clinical isolate of Leishmania donovani. The present study was designed to explore the potential role of the PCNA protein in SAG resistance in L. donovani. For this purpose, the protein was cloned, overexpressed, purified, and modeled. Western blot (WB) and real-time PCR (RT-PCR) analyses confirmed that PCNA was overexpressed by >= 3-fold in the log phase, stationary phase, and peanut agglutinin isolated procyclic and metacyclic stages of the promastigote form and by similar to 5-fold in the amastigote form of the SAG-resistant isolate compared to that in the SAG-sensitive isolate. L. donovani PCNA (LdPCNA) was overexpressed as a green fluorescent protein (GFP) fusion protein in a SAG-sensitive clinical isolate of L. donovani, and modulation of the sensitivities of the transfectants to pentavalent antimonial (Sb-V) and trivalent antimonial (Sb-III) drugs was assessed in vitro against promastigotes and intracellular (J774A.1 cell line) amastigotes, respectively. Overexpression of LdPCNA in the SAG-sensitive isolate resulted in an increase in the 50% inhibitory concentrations (IC50) of Sb-V (from 41.2 +/- 0.6 mu g/ml to 66.5 +/- 3.9 mu g/ml) and Sb-III (from 24.0 +/- 0.3 mu g/ml to 43.4 +/- 1.8 mu g/ml). Moreover, PCNA-overexpressing promastigote transfectants exhibited less DNA fragmentation compared to that of wild-type SAG-sensitive parasites upon SbIII treatment. In addition, SAG-induced nitric oxide (NO) production was found to be significantly inhibited in the macrophages infected with the transfectants compared with that in wild-type SAG-sensitive parasites. Consequently, we infer that LdPCNA has a significant role in SAG resistance in L. donovani clinical isolates, which warrants detailed investigations regarding its mechanism.
引用
收藏
页码:2997 / 3007
页数:11
相关论文
共 43 条
[1]   The relationship between leishmaniasis and AIDS:: the second 10 years [J].
Alvar, Jorge ;
Aparicio, Pilar ;
Aseffa, Abraham ;
Den Boer, Margriet ;
Canavate, Carmen ;
Dedet, Jean-Pierre ;
Gradoni, Luigi ;
Ter Horst, Rachel ;
Lopez-Velez, Rogelio ;
Moreno, Javier .
CLINICAL MICROBIOLOGY REVIEWS, 2008, 21 (02) :334-+
[2]   Leishmaniasis and poverty [J].
Alvar, Jorge ;
Yactayo, Sergio ;
Bern, Caryn .
TRENDS IN PARASITOLOGY, 2006, 22 (12) :552-557
[3]   Molecular mechanisms of antimony resistance in Leishmania [J].
Ashutosh ;
Sundar, Shyam ;
Goyal, Neena .
JOURNAL OF MEDICAL MICROBIOLOGY, 2007, 56 (02) :143-153
[4]   Downregulation of Mitogen-Activated Protein Kinase 1 of Leishmania donovani Field Isolates Is Associated with Antimony Resistance [J].
Ashutosh ;
Garg, Mansi ;
Sundar, Shyam ;
Duncan, Robert ;
Nakhasi, Hira L. ;
Goyal, Neena .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (01) :518-525
[5]  
Basu JM, 2006, ANTIMICROB AGENTS CH, V50, P1788, DOI [10.1128/AAC.50.5.1768-1797.2006, 10.1128/AAC.50.5.1788-1797.2006]
[7]   Multiple sequence alignment with the Clustal series of programs [J].
Chenna, R ;
Sugawara, H ;
Koike, T ;
Lopez, R ;
Gibson, TJ ;
Higgins, DG ;
Thompson, JD .
NUCLEIC ACIDS RESEARCH, 2003, 31 (13) :3497-3500
[8]   Identification of a Leishmania infantum gene mediating resistance to miltefosine and SbIII [J].
Choudhury, Kohelia ;
Zander, Dorothea ;
Kube, Michael ;
Reinhardt, Richard ;
Clos, Joachim .
INTERNATIONAL JOURNAL FOR PARASITOLOGY, 2008, 38 (12) :1411-1423
[9]   Drug resistance in leishmaniasis [J].
Croft, SL ;
Sundar, S ;
Fairlamb, AH .
CLINICAL MICROBIOLOGY REVIEWS, 2006, 19 (01) :111-+
[10]  
Cruz I, 2006, INDIAN J MED RES, V123, P357